Mice deficient in cystathionine beta synthase display increased Dyrk1A and SAHH activities in brain

Journal of Molecular Neuroscience

Volumn 50, Issue 1, 2013, Pages 1-6

  Planque, Chris ^a   Dairou, Julien ^a,b   Noll, Christophe ^a   Bui, Linh Chi ^a,b   Ripoll, Clémentine ^a   Guedj, Fayçal ^a   Delabar, Jean Maurice ^a   Janel, Nathalie ^a  

^a Groupe Hospitalier Pitié Salpêtrière   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Brain; Cystathionine beta synthase; DYRK1A; Hyperhomocysteinemia; Mice; S Adenosylhomocysteine hydrolase

Indexed keywords

ADENOSYLHOMOCYSTEINASE; CYSTATHIONINE BETA SYNTHASE; DUAL SPECIFICITY TYROSINE (Y) PHOSPHORYLATION REGULATED KINASE 1A; MESSENGER RNA; PRESENILIN 1; PROTEIN SERINE THREONINE KINASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN; COGNITION; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN SYNDROME; ENZYME ACTIVITY; FEMALE; GENE OVEREXPRESSION; HYPERHOMOCYSTEINEMIA; MALE; METHYLATION; MOUSE; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING;

ADENOSYLHOMOCYSTEINASE; ANIMALS; BRAIN; CYSTATHIONINE BETA-SYNTHASE; HYPERHOMOCYSTEINEMIA; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PROTEIN-SERINE-THREONINE KINASES; PROTEIN-TYROSINE KINASES;

MUS; MUS MUSCULUS;

EID: 84876044654     PISSN: 08958696     EISSN: 15591166     Source Type: Journal    
DOI: 10.1007/s12031-012-9835-0     Document Type: Article

References (27)

1. Baek KH, Zaslavsky A, Lynch RC, Britt C, Okada Y, Siarey RJ et al (2009) Down's syndrome suppression of tumour growth and the role of the calcineurin inhibitor DSCR1. Nature 459:1126-1130
2. Becker W, Sippl W (2011) Activation, regulation, and inhibition of DYRK1A. FEBS J 278:246-256
3. Chang HS, Lin CH, Yang CH, Yen MS, Lai CR, Chen YR et al (2007) Increased expression of Dyrk1a in HPV16 immortalized keratinocytes enable evasion of apoptosis. Int J Cancer 120:2377-2385 (Pubitemid 46642124)
4. Ferrer I, Barrachina M, Puig B, Martínez de Lagrán M, Martí E, Avila J, Dierssen M (2005) Constitutive Dyrk1A is abnormally expressed in Alzheimer disease, Down syndrome, Pick disease, and related transgenic models. Neurobiol Dis 20:392-400 (Pubitemid 41476265)
5. Fotaki V, Dierssen M, Alcántara S, Martínez S, Martí E, Casas C et al (2002) Dyrk1A haploinsufficiency affects viability and causes developmental delay and abnormal brain morphology in mice. Mol Cell Biol 22:6636-6647
6. Guedj F, Pereira PL, Najas S, Barallobre MJ, Chabert C, Souchet B et al (2012) DYRK1A: a master regulatory protein controlling brain growth. Neurobiol Dis 46:190-203
7. Hamelet J, Noll C, Ripoll C, Paul JL, Janel N, Delabar JM (2009) Effect of hyperhomocysteinemia on the protein DYRK1A in liver of mice. Biochem Biophys Res Commun 378:673-677
8. Han JM, Lee YJ, Lee SY, Kim EM, Moon Y, Kim HW, Hwang O (2007) Protective effect of sulforaphane against dopaminergic cell death. J Pharmacol Exp Ther 321:249-256 (Pubitemid 46456990)
9. Hershfield MS, Aiyar VN, Premakumar R, Small WC (1985) S-Adenosylhomocysteine hydrolase from human placenta. Affinity purification and characterization. Biochem J 230:43-52 (Pubitemid 16247268)
10. Kamath AF, Chauhan AK, Kisucka J, Dole VS, Loscalzo J, Handy DE et al (2006) Elevated levels of homocysteine compromise blood-brain barrier integrity in mice. Blood 107:591-593 (Pubitemid 43090794)
11. Leal JF, Ferrer I, Blanco-Aparicio C, Hernández-Losa J, Ramón Y, Cajal S et al (2008) S-Adenosylhomocysteine hydrolase downregulation contributes to tumorigenesis. Carcinogenesis 29:2089-2095
12. Mattson MP, Shea TB (2003) Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders. Trends Neurosci 26:137-146 (Pubitemid 36183675)
13. Mudd SH, Skovby F, Levy HL, Pettigrew KD, Wilcken B, Pyeritz RE (1985) The natural history of homocystinuria due to cystathionine beta-synthase deficiency. Am J Hum Genet 37:1-31 (Pubitemid 15138674)
14. Mudd SH (2011) Hypermethioninemias of genetic and non-genetic origin: a review. Am J Med Genet C 157:3-32
15. Noll C, Planque C, Ripoll C, Guedj F, Diez A, Ducros V et al (2009) DYRK1A, a novel determinant of the methionine-homocysteine cycle in different mouse models overexpressing this Down-syndrome-associated kinase. PLoS One 4:e7540
16. Obeid R, Herrmann W (2006) Mechanisms of homocysteine neurotoxicity in neurodegenerative diseases with special reference to dementia. FEBS Lett 580:2994-3005 (Pubitemid 43744523)
17. Raaf L, Noll C, Cherifi M, Benazzoug Y, Delabar JM, Janel N (2010) Hyperhomocysteinemia induced Dyrk1a downregulation results in cardiomyocyte hypertrophy rats. Int J Cardiol 145:306-307
18. obert K, Santiard-Baron D, Chassé JF, Paly E, Aupetit J, Kamoun K et al (2004) The neuronal SAPK/JNK pathway is altered in a murine model of hyperhomocysteinemia. J Neurochem 89:33-43 (Pubitemid 38420672)
19. Robert K, Pages C, Ledru A, Delabar J, Caboche J, Janel N (2005) Regulation of extracellular signal-regulated kinase by homocysteine in hippocampus. Neuroscience 133:925-935 (Pubitemid 40814601)
20. Ronan A, Fagan K, Christie L, Conroy J, Nowak NJ, Turner G (2007) Familial 4.3 Mb duplication of 21q22 sheds new light on the Down syndrome critical region. J Med Genet 44:448-451 (Pubitemid 47056871)
21. Ryoo SR, Cho HJ, Lee HW, Jeong HK, Radnaabazar C, Kim YS et al (2008) Dual-specificity tyrosine(Y)-phosphorylation regulated kinase 1A-mediated phosphorylation of amyloid precursor protein: evidence for a functional link between Down syndrome and Alzheimer's disease. J Neurochem 104:1333-1344 (Pubitemid 351293338)
22. Ryu YS, Park SY, Jung MS, Yoon SH, Kwen MY, Lee SY et al (2010) Dyrk1A-mediated phosphorylation of Presilin 1: a functional link between Down syndrome and Alzheimer's disease. J Neurochem 115:574-584
23. Sachdev PS, Valenzuela M, Wang XL, Looi JC, Brodaty H (2002) Relationship between plasma homocysteine levels and brain atrophy in healthy elderly individuals. Neurology 58:1539-1541 (Pubitemid 34552965)
24. Selhub J (1999) Homocysteine metabolism. Annu Rev Nutr 19:217-246 (Pubitemid 29380603)
25. Watanabe M, Osada J, Aratani Y, Kluckman K, Reddick R, Malinow MR, Maeda N (1995) Mice deficient in cystathionine beta-synthase: animal models for mild and severe homocyst(e)inemia. Proc Natl Acad Sci USA 92:1585-1589
26. Yu S, Khor TO, Cheung KL, Li W, Wu TY, Huang Y et al (2010) Nrf2 expression is regulated by epigenetic mechanisms in prostate cancer of TRAMP mice. PloS ONE 5:e8579
27. Zhang CE, Wei W, Liu YH, Peng JH, Tian Q, Liu GP et al (2009) Hyperhomocysteinemia increases beta-amyloid by enhancing expression of gamma-secretase and phosphorylation of amyloid precursor protein in rat brain. Am J Pathol 174:1481-1491